The Pharmacokinetic Profile of a Single Dose of Ferriprox in Patients With Sickle Cell Disease

Trial Profile

The Pharmacokinetic Profile of a Single Dose of Ferriprox in Patients With Sickle Cell Disease

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Jul 2015

At a glance

  • Drugs Deferiprone (Primary)
  • Indications Sickle cell anaemia
  • Focus Pharmacokinetics
  • Sponsors ApoPharma
  • Most Recent Events

    • 11 Jul 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
    • 30 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top